RPS19P7

Across TCGA pan-cancer cohorts, RPS19P7 RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of RPS19P7’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RPS19P7 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPS19P7 is over-expressed in tumor, although a few such as BRCA show the opposite, repressed pattern.

COAD, KIRC, and STAD are the cancer types where RPS19P7 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS19P7 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	II,III,IV	+1.751	<.001	10	view →
KIRC	Male	All	+0.293	<.001	10	view →
STAD	All	All	+0.689	.008	6	view →
LUSC	All	All	+0.189	.002	4	view →
LIHC	All	II,III,IV	+0.154	.005	4	view →
ESCA	All	All	+0.937	.022	2	view →
READ	All	All	+0.632	.030	2	view →
LUAD	All	All	+0.228	.001	2	view →
CHOL	All	All	+0.155	.003	2	view →
BRCA	Female	All	−0.104	.023	2	view →
THCA	Female	II,III,IV	+0.212	.020	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 11 strongest of 11 lineages.

RPS19P7–COAD

Open the COAD breakdown →